Balint Journal 2010; 11(2): 39-41
DOI: 10.1055/s-0030-1247399
Originalarbeit

© Georg Thieme Verlag Stuttgart ˙ New York

Der Arzt als Plazebo

The Physician as a PlaceboF. Zimmermann-Viehoff1
  • 1Abteilung für Psychosomatik und Psychotherapie, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin
Further Information

Publication History

Publication Date:
17 June 2010 (online)

Zusammenfassung

Plazeboeffekte sind in medizinischen Kontexten allgegenwärtige Phänomene. Die Arzt-Patienten-Beziehung wird hinsichtlich des therapeutischen Nutzens unspezifischer Interventionen als entscheidend angesehen. In unserem Essay möchten wir anhand ausgesuchter Studien zum Plazebo­effekt aufzeigen, welche Bedeutung Suggestionen, therapeutische Rituale, Bindung und die emotionalen Fähigkeiten des Arztes für einen positiven Therapieverlauf haben.

Abstract

Placebo effects are omnipresent phenomena in medical contexts. The physician-patient relationship is believed to be the crucial factor with regard to the therapeutic potential of unspecific interventions. In this essay, a selective review of studies targeting the placebo effect is used to point out how suggestions, therapeutic rituals, ­attachment, and the emotional skills of the physician can positively affect therapeutic outcome.

Literatur

  • 1 De la Fuente-Fernandez R, Stoessl A J. The placebo effect in Parkinson’s disease.  Trend Neurosci. 2001;  25(6) 302-306
  • 2 Beecher H K. The powerful placebo.  J Am Med Assoc. 1955;  159(17) 1602-1606
  • 3 Levine J D, Gordon N C, Fields H L. The mechanism of placebo analgesia.  Lancet. 1978;  2(8091) 654-657
  • 4 Benedetti F, Mayberg H S, Wager T D et al. Neurobiological mechanisms of the placebo effect.  J Neurosci. 2005;  25(45) 10390-10402
  • 5 Klosterhalfen S, Enck P. Psychobiology of the placebo response.  Auton Neurosci. 2006;  125 94-99
  • 6 Linde K, Witt C M, Streng A et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain.  Pain. 2007;  128(3) 264-271
  • 7 Crum A J, Langer E J. Mind-set matters: exercise and the placebo effect.  Psychol Sci. 2007;  18(2) 165-171
  • 8 Kaptchuk T J, Stason W B, Davis R B et al. Sham device vs. inert pill: randomised controlled trial of two placebo treatments.  BMJ. 2006;  332(7538) 391-397
  • 9 Waber R L, Shiv B, Carmon Z et al. Commercial features of placebo and therapeutic efficacy.  JAMA. 2008;  299(9) 1016-1017
  • 10 Branthwaite A, Cooper P. Analgesic effects of branding in treatment of headaches.  Br Med J (Clin Res Ed). 1981;  282(6276) 1576-1578
  • 11 de la Fuente-Fernández R, Schulzer M, Stoessl A J. Placebo mechanisms and reward circuitry: clues from Parkinson’s disease.  Biol Psychiatry. 2004;  56(2) 67-71
  • 12 Moseley J B, O’Malley K, Petersen N J et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee.  N Engl J Med. 2002;  347(2) 81-88
  • 13 Green S A. Surgeons and shamans: the placebo value of ritual.  Clin Orthop Relat Res. 2006;  450 249-254
  • 14 Bowlby J. Attachment and loss. Vol. 1. New York, Basic Books, 1969
  • 15 Enck P, Klosterhalfen S. The story of O – is oxytocin the mediator of the placebo response?.  Neurogastroenterol Motil. 2009;  21(4) 347-350
  • 16 Colloca L, Lopiano L, Lanotte M et al. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease.  Lancet Neurol. 2004;  3(11) 679-684
  • 17 Gracely R H, Dubner R, Deeter W R et al. Clinicians’ expectations influence placebo analgesia.  Lancet. 1985;  1(8419) 43
  • 18 Di Blasi Z, Harkness E, Ernst E et al. Influence of context effects on health outcome: a systematic review.  Lancet. 2001;  357 757-762
  • 19 Kaptchuk T J, Kelley J M, Conboy L A et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.  BMJ. 2008;  336(7651) 999-1003
  • 20 Kelley J M, Lembo A J, Ablon J S et al. Patient and practitioner influences on the placebo effect in irritable bowel syndrome.  Psychosom Med. 2009;  71(7) 789-797
  • 21 Hyland M E. A tale of two therapies: psychotherapy and complementary and alternative medicine (CAM) and the human effect.  Clin Med. 2005;  5(4) 361-367

Dr. F. Zimmermann-Viehoff

Abteilung für Psychosomatik und Psychotherapie · Charité Universitätsmedizin Berlin · Campus Benjamin Franklin

Hindenburgdamm 30

12200 Berlin

Email: frank.zimmermann@charite.de